These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 19080135
21. Submandibular and sublingual glands involvement in advanced acquired immunodeficiency syndrome (AIDS): an autopsy-based study. León JE, Mauad T, Saldiva PH, Almeida OP, Vargas PA. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):216-26. PubMed ID: 19464206 [Abstract] [Full Text] [Related]
24. [Value of the detection of serum anti-cytomegalovirus antibodies applied to the diagnosis of recent infection]. Harzic M, Mazeron MC, Bertrand C. Ann Med Interne (Paris); 1987 Aug; 138(5):331-3. PubMed ID: 2823656 [Abstract] [Full Text] [Related]
25. CMV-IGG avidity and CMV-IGM concentration in both immunocompromised and immunocompetent patients. Dussaix E, Chantot S, Harzic M, Grangeot-Keros L. Pathol Biol (Paris); 1996 May; 44(5):405-10. PubMed ID: 8758485 [Abstract] [Full Text] [Related]
26. Ocular manifestations of HIV infection. Jabs DA. Trans Am Ophthalmol Soc; 1995 May; 93():623-83. PubMed ID: 8719695 [Abstract] [Full Text] [Related]
27. [Symptomatic cytomegalovirus infection in patients with acquired immunodeficiency syndrome]. Aukrust P, Frøland SS, Kvale D, Egge K, Farstad IN, Holter E, Moum B. Tidsskr Nor Laegeforen; 1991 Nov 20; 111(28):3379-84. PubMed ID: 1665253 [Abstract] [Full Text] [Related]
28. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART. Tamarit A, Alberola J, Mir A, Benet I, Mira JV, Muñoz C, Galindo MJ, Navarro D. J Clin Virol; 2004 Apr 20; 29(4):308-14. PubMed ID: 15018860 [Abstract] [Full Text] [Related]
30. [The characteristics of opportunistic infections in 181 HIV/AIDS patients in China]. Wang XC, Huang XJ, Zhang T, Liang LC, Jiao YM, Zhang HW, Wu H. Zhonghua Nei Ke Za Zhi; 2007 May 20; 46(5):379-82. PubMed ID: 17637305 [Abstract] [Full Text] [Related]
31. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells. Bronke C, Westerlaken GH, Miedema F, Tesselaar K, van Baarle D. Immunol Lett; 2005 Mar 15; 97(2):215-24. PubMed ID: 15752561 [Abstract] [Full Text] [Related]
32. Evaluation of cytomegalovirus (CMV)-specific T-cell immunity for the assessment of the risk of active CMV infection in non-immunosuppressed surgical and trauma intensive care unit patients. Clari MA, Aguilar G, Benet I, Belda J, Giménez E, Bravo D, Carbonell JA, Henao L, Navarro D. J Med Virol; 2013 Oct 15; 85(10):1802-10. PubMed ID: 23868746 [Abstract] [Full Text] [Related]
35. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy. Kempen JH, Martin BK, Wu AW, Barron B, Thorne JE, Jabs DA, Studies of Ocular Complications of AIDS Researh Group. Ophthalmology; 2003 May 15; 110(5):987-95. PubMed ID: 12750102 [Abstract] [Full Text] [Related]
36. HIV infection and AIDS. Lloyd A. P N G Med J; 1996 Sep 15; 39(3):174-80. PubMed ID: 9795558 [Abstract] [Full Text] [Related]
37. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy. Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR. Retina; 2000 Sep 15; 20(2):151-5. PubMed ID: 10783947 [Abstract] [Full Text] [Related]